Back
Akebia Therapeutics Vs. Stoke Therapeutics Industry Stock Comparison
Sell
42
AKBA
Akebia Therapeutics
Last Price:
1.16
Seasonality Move:
-7.41%
Buy
62
STOK
Stoke Therapeutics
Last Price:
13.90
Seasonality Move:
-5.15%
Sell
42
Akebia Therapeutics (AKBA)
is a Sell
Is Akebia Therapeutics a Buy, Sell or Hold?
- The current Akebia Therapeutics [AKBA] share price is $1.15. The Score for AKBA is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
- AKBA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
62
Stoke Therapeutics (STOK)
is a Buy
Is Stoke Therapeutics a Buy, Sell or Hold?
- The current Stoke Therapeutics [STOK] share price is $13.90. The Score for STOK is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
- STOK is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
AKBA Stock Price Chart
What is Akebia Therapeutics's stock price today?
-
The Akebia Therapeutics share price today is $1.15
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AKBA is experiencing slight selling pressure.
STOK Stock Price Chart
What is Stoke Therapeutics's stock price today?
-
The Stoke Therapeutics share price today is $13.90
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and STOK is experiencing slight selling pressure.
AKBA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.08 | Sell |
Relative Strength Index (14 RSI): | 36.32 | Sell |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.23 - 1.41) | Sell |
Bollinger Bands (100): | (1.29 - 1.73) | Sell |
STOK Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.64 | Buy |
Relative Strength Index (14 RSI): | 65.33 | Buy |
Chaikin Money Flow: | -111158 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (11.26 - 12.9) | Buy |
Bollinger Bands (100): | (4.85 - 11.59) | Buy |
AKBA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.24 | Sell |
20-day SMA: | 1.3 | Sell |
50-day SMA: | 1.5 | Sell |
200-day SMA: | 1.31 | Sell |
8-day EMA: | 1.22 | Sell |
20-day EMA: | 1.31 | Sell |
50-day EMA: | 1.41 | Sell |
200-day EMA: | 1.32 | Sell |
STOK Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 12.69 | Buy |
20-day SMA: | 12.09 | Buy |
50-day SMA: | 10.93 | Buy |
200-day SMA: | 6.41 | Buy |
8-day EMA: | 13.03 | Buy |
20-day EMA: | 12.35 | Buy |
50-day EMA: | 10.95 | Buy |
200-day EMA: | 8.26 | Buy |
Akebia Therapeutics Earnings Growth & AKBA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, an increase next quarter of $0.10 per share, an increase this year of $0.05 per share, and an increase next year of $0.05 per share.
Stoke Therapeutics Earnings Growth & STOK Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and a decrease next year of $0.35 per share.
Akebia Therapeutics Technical Analysis
May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Stoke Therapeutics Technical Analysis
May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |